The BIO International Convention 2026 is the world’s largest and most comprehensive event for the biotechnology and biopharmaceutical industries. Organized by the Biotechnology Innovation Organization (BIO), the event serves as a global hub for scientific innovation, strategic partnerships, and deal-making.
With over 20,000 attendees from 100+ countries and 1,600+ exhibitors, BIO 2026 brings together leaders across pharma, biotech, and investment sectors. The event features structured partnering meetings, technical sessions, and discussions focused on cutting-edge areas such as cell and gene therapy, oncology, AI-driven drug discovery, and personalized medicine.
Drug discovery, development, and therapeutic innovation.
Biomanufacturing, contract development, and production services.
Platforms for drug discovery, clinical trials, and data analytics.
Trial management, patient recruitment, and research services.
Compliance, intellectual property, and global market access advisory.
Funding, partnerships, and biotech startup support.
Decision-makers driving R&D and commercialization strategies.
Experts advancing therapies and biomedical innovation.
Professionals focused on partnerships, licensing, and deals.
Stakeholders funding biotech innovation and growth.
Experts managing approvals and compliance.
Emerging companies seeking funding and collaboration.
Reach executives, researchers, and investors in biotech and pharma.
All contacts are verified and regularly updated.
Engage prospects before partnering meetings and follow up after.
Receive campaign-ready datasets quickly.
Ideal for B2B outreach, partnerships, and deal-making.
Aligned with applicable healthcare and data protection standards.
Access past and upcoming event editions with verified attendee and exhibitor email lists. Get accurate contact details of event attendees, key decision-makers, and exhibiting companies to power targeted B2B outreach and lead generation.





Our process is designed to deliver accurate, event-specific contact data while maintaining quality, relevance, and compliance at every stage.
We collect contact information exclusively from real expos, trade shows, conferences, and business events using trusted online and offline sources. This ensures our databases are built around active, relevant audiences, not generic or unrelated records.
Once data is collected, missing or incomplete fields are appended to create detailed and usable contact profiles. This includes company details, job roles, industry information, and event relevance to support targeted outreach.
Every contact record goes through validation checks to improve accuracy and reduce outdated or invalid information. Our review process helps ensure better data quality and improved campaign performance.
Target contacts by specific events, industries, job roles, company size, or locations for focused and effective outreach.
Connect with leaders across pharma, biotech, and investment sectors.
Engage stakeholders involved in R&D and commercialization.
Access a global audience of innovators and investors.
Engage decision-makers in licensing, funding, and collaboration.
Connect with CDMOs, CROs, and biotech startups.
Convert high-intent prospects into long-term partners.
Request curated attendee and exhibitor data from top global trade shows, verified, updated, and ready for targeted outreach.
Click HereThe list focuses on exhibiting companies and verified professional attendees.
Yes. The data is curated specifically for B2B outreach in biotechnology, pharmaceuticals, and healthcare innovation markets.
Excel or CSV formats compatible with CRM and marketing platforms.